323008 SE Case Studies in Drug Discovery and Preclinical Drug Development - MPS7 (2022S)
(2 Courses)
Prüfungsimmanente Lehrveranstaltung
Labels
Details
Sprache: Englisch
Lehrende
Termine
25 April (Monday) 9.00 - 10.00 Uhr s.t.
Case Study 1 (Nussbaumer, Lead Discovery):
-28 April 16:30 -18:30
-19 May 16:30 - 18:30
-21 June 16:30 - 18:30
Case Study 2 (Ettmayer, Boehringer Ingelheim):
-26 April 8:30 - 10:30
-12 May 8:30 - 10:30
-08 June 8:30 - 10:30
Case Study 3 (Boss & Roch, Idorsia):
-27 April 13:00 - 15:00
-13 May 14:00 - 16:00
-03 June 14:00 - 16:00
Information
Ziele, Inhalte und Methode der Lehrveranstaltung
Students will work in small teams on case studies to conceptualise concrete drug development project proposals, discuss the case study topics and revise their proposals with the supervisors. The case study will involve a real project conducted in industry. The outcomes from the industry research project will be revealed in the final lecture. The course will consist of Introduction to the course, two lectures, 3 assignments, and 3 feedback/discussion teaching sessions.
Art der Leistungskontrolle und erlaubte Hilfsmittel
Students must attend all sessions and actively participate in the discussion, complete and submit all of the assignments on time. They are expected to incorporate feedback and discussion outcomes into their revised final project proposal that is due before the last day of class.
Mindestanforderungen und Beurteilungsmaßstab
Enrollment in the Master of Drug Discovery and Development program. Successful completion of MPS1 in the Master of Drug Discovery and Development program. Course attendance; completion of assignments including revisions from feedback sessions to be submitted to instructors for evaluation. Final presentation to be submitted and given on last day of course and final revised proposal to be submitted to instructors.
Prüfungsstoff
Literatur
To be given in class
Zuordnung im Vorlesungsverzeichnis
Letzte Änderung: Di 25.01.2022 13:09